Medullary Thyroid Cancer Clinical Trials
3 recruiting trials for Medullary Thyroid Cancer. Eligibility criteria explained in plain English.
3
Total Trials
3
Recruiting Now
0
Phase 3 Trials
3
Sponsors
Recruiting Trials
RECRUITINGPhase 1 / Phase 2NCT06814496
Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
Phase I study to examine safety of the addition of concurrent tarlatamab with standard palliative and consolidative RT regimens , with a main cohort of N=20-24 patients with...
Sponsor: University of ArizonaEnrolling: 301 location
RECRUITINGPhase 4NCT05830500
Study of Anlotinib in Patients With Advanced Medullary Thyroid Carcinoma
This is a real world study aiming to observe the efficacy and safety of Anlotinib capsules in patients with advanced medullary thyroid carcinoma, and to summarize the treatment...
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Enrolling: 36019 locations
RECRUITINGNCT06277180
68Ga-TCR-FAPI PET/CT Guided Precision Surgery for MTC
This is a phase II clinical trial to evaluate the capability of 68Ga-labeled targeted covalent radiopharmaceutical (TCR) fibroblast activation protein inhibitor (FAPI) PET/CT to...
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical SciencesEnrolling: 501 location